BMO Capital Markets Issues Positive Forecast for Veeva Systems (NYSE:VEEV) Stock Price

Key Points

• BMO Capital Markets raised its Veeva Systems price target to $270 from $175 while maintaining a “market perform” rating, implying roughly 5% downside from the prior close. The broader analyst consensus remains “Moderate Buy,” with an average target of $280.58.
• Veeva reported quarterly adjusted EPS of $2.35 and revenue of approximately $928 million, beating analyst expectations of $2.22 and $905.4 million, respectively. Management also raised fiscal 2027 guidance to about $3.7 billion in revenue and $9.21 EPS.
• Shares jumped 16.3% to $284.77, but the stock trades at a premium valuation near 50.8 times forward earnings. Analysts remain divided, with some citing upside from Vault CRM and emerging Falcon AI demand while others warn that much of the optimism may already be priced in.

Veeva Systems (NYSE:VEEV - Get Free Report) had its price objective hoisted by stock analysts at BMO Capital Markets from $175.00 to $270.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has a "market perform" rating on the technology company's stock. BMO Capital Markets' price target would suggest a potential downside of 5.19% from the company's previous close.

Other research analysts also recently issued reports about the company. Wells Fargo & Company boosted their price target on Veeva Systems from $317.00 to $320.00 and gave the company an "overweight" rating in a report on Thursday, June 4th. UBS Group upped their price objective on shares of Veeva Systems from $190.00 to $290.00 and gave the stock a "neutral" rating in a research report on Thursday. TD Cowen boosted their price target on shares of Veeva Systems from $235.00 to $283.00 and gave the stock a "buy" rating in a research report on Monday. The Goldman Sachs Group cut their price objective on shares of Veeva Systems from $190.00 to $165.00 and set a "sell" rating for the company in a report on Thursday, June 4th. Finally, Weiss Ratings upgraded Veeva Systems from a "hold (c-)" rating to a "hold (c)" rating in a report on Wednesday, August 12th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $280.58.

Veeva Systems Stock Up 16.3%

Shares of NYSE:VEEV traded up $39.86 during midday trading on Thursday, reaching $284.77. The company's stock had a trading volume of 3,592,252 shares, compared to its average volume of 2,461,212. The stock has a fifty day moving average of $203.41 and a 200 day moving average of $183.04. Veeva Systems has a twelve month low of $148.05 and a twelve month high of $310.50. The firm has a market capitalization of $46.26 billion, a PE ratio of 50.74, a P/E/G ratio of 1.06 and a beta of 0.92.

Veeva Systems (NYSE:VEEV - Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.22 by $0.13. The company had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The firm's revenue was up 17.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Sell-side analysts anticipate that Veeva Systems will post 6.65 earnings per share for the current fiscal year.

Insider Activity at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the company's stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the transaction, the insider directly owned 19,449 shares in the company, valued at approximately $4,866,723.27. This represents a 64.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by company insiders.

Institutional Trading of Veeva Systems

A number of institutional investors have recently bought and sold shares of the company. Empire Life Investments Inc. boosted its position in shares of Veeva Systems by 21.1% in the 4th quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company's stock worth $8,272,000 after buying an additional 6,453 shares in the last quarter. Czech National Bank purchased a new position in shares of Veeva Systems during the 2nd quarter worth approximately $7,584,000. BNP Paribas raised its holdings in shares of Veeva Systems by 89.3% in the fourth quarter. BNP Paribas now owns 19,239 shares of the technology company's stock worth $4,308,000 after acquiring an additional 9,077 shares during the last quarter. ABN Amro Investment Solutions lifted its holdings in Veeva Systems by 28.4% in the 4th quarter. ABN Amro Investment Solutions now owns 76,809 shares of the technology company's stock valued at $17,146,000 after purchasing an additional 17,007 shares in the last quarter. Finally, AustralianSuper Pty Ltd acquired a new stake in Veeva Systems during the fourth quarter worth approximately $2,453,000. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Fiscal Q2 revenue rose 17.6% year over year to approximately $928 million, exceeding the $905.4 million analyst consensus. Adjusted earnings of $2.35 per share also surpassed expectations of $2.22 and increased from $1.99 in the prior-year quarter. Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up
• Positive Sentiment: Management raised fiscal 2027 guidance to approximately $3.7 billion in revenue and $9.21 in earnings per share, above consensus estimates of about $3.6 billion and $8.58, respectively. Third-quarter revenue guidance of $932 million to $935 million and EPS guidance of $2.33 to $2.34 also exceeded analyst expectations. Veeva Announces Fiscal 2027 Second Quarter Results
• Positive Sentiment: Strong Vault CRM execution, including a record quarter, supported confidence that Veeva can maintain more than 70% market share. Falcon AI demand is building, with the company expecting its first customer go-lives this year. Veeva Targets Maintaining CRM Share as Falcon Go-Lives Begin
• Positive Sentiment: Several analysts lifted their price targets following the results. RBC raised its target to $325 and kept an outperform rating, while Barclays raised its target to $315 with an overweight rating. Guggenheim and Truist also raised targets to $310 and $305, respectively.
• Neutral Sentiment: Other analysts remained cautious despite raising targets: UBS set a $290 target with a neutral rating, Canaccord set $260 with a hold rating, and Morgan Stanley set $275 with an equal-weight rating. These targets indicate that some firms view much of the earnings optimism as already reflected in the stock.
• Negative Sentiment: At a roughly 50.8 forward? P/E ratio as reported, Veeva carries a premium valuation, leaving the shares sensitive to any slowdown in growth, weaker AI adoption, or future guidance disappointments.

Veeva Systems Company Profile

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source